The focus of the market, in particular, the orlistat market is to market its most popular prescription medicines, as well as sell its most commonly used treatment, metformin. This segment has been experiencing significant growth over the years, driven by several factors contributing to its increasing demand.
The orlistat market, in particular, has experienced significant growth driven by several key factors:
We are currently focusing on regions:
The Asia-Pacific, also known as APEXedentaryzannene is a market segment of orlistat from USP and European Pharmacopoeia.
The Asia-Pacific/Other Regions is growing at a CAGR of 2.24% from this period.
In the orlistat market, the growth rate of orlistat has been steady and increasing, driven by the increasing demand from consumers, as well as the availability of generic orlistat from brand-name manufacturers, such as gliclazide (Laxative®), or orlistat (Orlistat®), due to its lower cost.
The orlistat market, in particular, is experiencing a notable growth trend:
Orlistat has been shown to cause mild side effects in some individuals. Talk to your health care provider if these do not go away within a few days. If you begin to experience more serious effects, seek medical attention immediately.
Common side effects of orlistat use include:
More serious side effects include:
If you experience any of these side effects, seek medical attention immediately. These are symptoms of a serious adverse reaction–or allergic reaction–to this medication and require treatment right away.
Orlistat has been shown to affect the absorption of fat-soluble vitamins (vitamin A, D, E and K). This can prevent individuals taking this medication from receiving valuable nutrients from their food. Your doctor may recommend that you take a multivitamin and beta-carotene supplement along with this medication to ensure that you are receiving adequate nutrition from the food you eat.
As with all medication, inform your health care provider of any medical conditions you are currently managing. Let them know if you have or ever had kidney stones, diabetes, liver disease, gallbladder disease, thyroid disease, or an eating disorder (anorexia or bulimia). In addition, you should tell them if you have ever had an organ transplant, cholestasis (reduced or stopped bile flow), or malabsorption syndrome.
Tell your provider about any and all medication, prescription drugs, and supplements you are taking before starting treatment with orlistat. Orlistat can interact with substances in the body, causing potentially serious adverse reactions. Specifically, you should inform them of any immunosuppressant medication you are currently taking, such as cyclosporine. You should also let your provider know if you are currently taking blood thinners–like warfarin–or diabetes medication–like metformin.
In addition, let your doctor know if you are planning to become pregnant, are pregnant, or are currently breastfeeding before starting treatment with this medication.
Let your doctor know if you are:You have a medical condition, are approved by the Food and Drug Administration (FDA) that affects individual skin, or prostate, hormones and/or medications. You have a disease process in hand, or kidney disease.
You have a deformed penis.
You have ever had an erection that was painful or lasted more than 4 hours.
You are pregnant, may you know you are pregnant or are breastfeeding, or are under- or are of child protection. You should not take this medication during the delivery of baby or personal items to your family.
Tell your doctor if you are pregnant, may you know you are pregnant or are breastfeeding. Notify your doctor if you are pregnant or plan to become pregnant.Let your doctor know if you are currently taking:You should know that orlistat has been prescribed for treatment of weight-related conditions before you begin this medication. Also, informing your doctor has made it known, "Orlistat" is a prescription medication used to help weight-related conditions. It is not known if orlistat is addictive.
If you are currently taking medication for any health condition, including any that affects your penis, you should not take this medication.
Tell your health care provider about all the medications, supplements you are currently taking, and herbal products you are currently using to avoid adverse reactions.
Salt Composition in both
Salt Composition
Orlistat 120mg(same for both)
You Searched
Strip of 21 capsules
We only sell the best substitute from top brands
Our Recommendation
Slimore 120mg Capsule 10s
Strip of 10 capsules
840+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
So after a few failed attempts at dieting, the only thing that really helped was to stick to a low-calorie diet and to take in more of the nutrients from the food you eat. But that's all well if it's just a handful of pounds, but when you consider the other nutrients in the diet, it can be a bit overwhelming. So, after nearly a decade of trying to lose weight by dieting alone, I've found that the only way to lose weight is to incorporate in it a healthy lifestyle and to incorporate in it a healthy diet.
Lipase Inhibitors are a group of medications that work by inhibiting the action of lipases, enzymes that play an essential role in many human diseases. They are often used as the first-line treatment for obesity and, in some cases, as an adjunct in other lipid-lowering therapies. Lipases are among the most frequently used lipase inhibitors, including Orlistat and Orlistat XR, in clinical practice. In this study, we assessed the effects of Orlistat (XR), Orlistat XR and Orlistat XR XR on lipase inhibition.
We evaluated the effects of Orlistat (XR) and Orlistat XR on lipase inhibition in humans with various lipase-producing and lipase-negative obesity disorders.
Orlistat (XR) had the lowest lipase inhibition rate in the patients with a body weight of 5–10 kg. Orlistat XR and Orlistat XR XR had the highest lipase inhibition rates, with Orlistat XR having the lowest lipase inhibition rate at a dose of 60 mg/day. Orlistat XR had the lowest lipase inhibition rate in patients with a body weight of 5–7 kg and Orlistat XR had the highest lipase inhibition rate at a dose of 20 mg/day. Orlistat XR had the lowest lipase inhibition rate in patients with a body weight of 5–7 kg and Orlistat XR had the highest lipase inhibition rate at a dose of 60 mg/day. Orlistat XR and Orlistat XR XR had similar effects on the lipase activity of the patients with a body weight of 5–7 kg and Orlistat XR had the highest lipase inhibition rate at a dose of 60 mg/day. The results of our study were consistent with previous clinical studies.
Orlistat (XR), Orlistat XR and Orlistat XR XR XR had similar effects on lipase inhibition in patients with various lipase-producing and lipase-negative obesity disorders. Orlistat (XR) had the lowest lipase inhibition rate in patients with a body weight of 5–7 kg and Orlistat XR had the highest lipase inhibition rate at a dose of 60 mg/day. Orlistat XR had similar effects on the lipase activity of the patients with a body weight of 5–7 kg and Orlistat XR had the highest lipase inhibition rate at a dose of 60 mg/day.
Citation:Carrillo JR, Cappello E, Ferro C, Gomes D, Giannini G, et al. (2014) Orlistat, Orlistat XR and Orlistat XR XR XR XR in the management of patients with obesity. PLoS ONE 9(11): e100882. https://doi.org/10.1371/journal.pone.1007882
Editor:Leandro A. Tosti, Massachusetts General Hospital, UNITED STATES
Received:June 9, 2013;Accepted:August 4, 2013;Published:August 11, 2013
Copyright:© 2014 Carrillo et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability:The original version of this article has been viewed in a PubMed Central PubMed Central Library.
Funding:This study was funded by the following grants: the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the National Institute of Clinical Excellence for the management of obesity (NIGMS), through the National Institute of Health (NIH) T32 EOR.
Competing interests:The authors have declared that no competing interests exist.
There are several different mechanisms through which lipoproteins function in various diseases and disorders.
Stade de France Pharmacy